Furthermore, the fact that stimulation of NFκB signaling was accomplished only by IL-17F, not IL-17A and occurred only in CLL B cells and not those from healthy donors is provocative, and the clinical association of this interaction is under study. Here, IL17F is linked to B-cell chronic lymphocytic leukemia.